Tirelli Medical Group, Pordenone (PN), Italy.
Eur Rev Med Pharmacol Sci. 2021 Jun;25(12):4422-4425. doi: 10.26355/eurrev_202106_26154.
The huge concern raised by SARS-CoV2 pandemic about public health management and social impact is still under debate, particularly because COVID-19 may affect infected people much longer than expected from a typical air-borne viral disease. The scientific community is actually wondering about the etiopathogenesis and clinical development of this "post-COVID" complex symptomatology, very close to symptoms typically observed in chronic fatigue syndrome, so recently named as "post-acute sequelae of COVID-19 (PASC)". This commentary tries to focus on the most recent news about this issue.
SARS-CoV2 大流行对公共卫生管理和社会影响的巨大关注仍在讨论中，特别是因为 COVID-19 可能比预期的典型空气传播病毒疾病感染时间更长。科学界实际上对这种“新冠后”复杂症状的病因和临床发展感到好奇，这种症状非常接近慢性疲劳综合征中观察到的症状，因此最近被命名为“COVID-19 后急性后遗症（PASC）”。本评论试图关注这一问题的最新消息。
